11.71 USD
-0.64 (-5.18%)
11.7197 USD
+0.01 (+0.08%)
We assign a fundamental rating of 4 out of 10 to TNGX. TNGX was compared to 525 industry peers in the Biotechnology industry. TNGX has a great financial health rating, but its profitability evaluates not so good. TNGX is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- TNGX had negative earnings in the past year.
- In the past year TNGX has reported a negative cash flow from operations.
- In the past 5 years TNGX always reported negative net income.
- In the past 5 years TNGX always reported negative operating cash flow.
1.2 Ratios
- TNGX has a Return On Assets of -47.83%. This is comparable to the rest of the industry: TNGX outperforms 53.14% of its industry peers.
- TNGX has a Return On Equity of -62.81%. This is comparable to the rest of the industry: TNGX outperforms 59.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.83% | ||
| ROE | -62.81% | ||
| ROIC | N/A |
ROA(3y)-30.42%
ROA(5y)-20.6%
ROE(3y)-49.57%
ROE(5y)-33.14%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- TNGX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- TNGX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for TNGX has been increased compared to 1 year ago.
- There is no outstanding debt for TNGX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 15.56 indicates that TNGX is not in any danger for bankruptcy at the moment.
- TNGX has a Altman-Z score of 15.56. This is amongst the best in the industry. TNGX outperforms 85.90% of its industry peers.
- There is no outstanding debt for TNGX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 15.56 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- A Current Ratio of 8.88 indicates that TNGX has no problem at all paying its short term obligations.
- TNGX has a better Current ratio (8.88) than 78.10% of its industry peers.
- A Quick Ratio of 8.88 indicates that TNGX has no problem at all paying its short term obligations.
- TNGX's Quick ratio of 8.88 is fine compared to the rest of the industry. TNGX outperforms 78.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.88 | ||
| Quick Ratio | 8.88 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 22.03% over the past year.
- The Revenue has grown by 53.28% in the past year. This is a very strong growth!
- TNGX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.34% yearly.
EPS 1Y (TTM)22.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%151.85%
Revenue 1Y (TTM)53.28%
Revenue growth 3Y4.34%
Revenue growth 5YN/A
Sales Q2Q%363.61%
3.2 Future
- The Earnings Per Share is expected to grow by 9.03% on average over the next years. This is quite good.
- TNGX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 39.53% yearly.
EPS Next Y24.88%
EPS Next 2Y-1.64%
EPS Next 3Y-5.73%
EPS Next 5Y9.03%
Revenue Next Year37.77%
Revenue Next 2Y-50.45%
Revenue Next 3Y-30.53%
Revenue Next 5Y39.53%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- TNGX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TNGX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- TNGX's earnings are expected to decrease with -5.73% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.64%
EPS Next 3Y-5.73%
5. Dividend
5.1 Amount
- TNGX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TANGO THERAPEUTICS INC / TNGX FAQ
What is the ChartMill fundamental rating of TANGO THERAPEUTICS INC (TNGX) stock?
ChartMill assigns a fundamental rating of 4 / 10 to TNGX.
What is the valuation status of TANGO THERAPEUTICS INC (TNGX) stock?
ChartMill assigns a valuation rating of 0 / 10 to TANGO THERAPEUTICS INC (TNGX). This can be considered as Overvalued.
What is the profitability of TNGX stock?
TANGO THERAPEUTICS INC (TNGX) has a profitability rating of 1 / 10.